BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32321773)

  • 21. Downregulated lncRNA-MIAT confers protection against erectile dysfunction by downregulating lipoprotein lipase via activation of miR-328a-5p in diabetic rats.
    Huo W; Hou Y; Li Y; Li H
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1226-1240. PubMed ID: 30660685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
    Pang B; Hao Y
    Front Oncol; 2021; 11():690486. PubMed ID: 34178688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of long non-coding RNA MIAT and miR-133 play a role in the proliferation and metastasis of pancreatic carcinoma.
    Li TF; Liu J; Fu SJ
    Biomed Pharmacother; 2018 Aug; 104():145-150. PubMed ID: 29772434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
    Smolle MA; Calin HN; Pichler M; Calin GA
    FEBS J; 2017 Jul; 284(13):1952-1966. PubMed ID: 28132417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint.
    Xu S; Tao Z; Hai B; Liang H; Shi Y; Wang T; Song W; Chen Y; OuYang J; Chen J; Kong F; Dong Y; Jiang SW; Li W; Wang P; Yuan Z; Wan X; Wang C; Li W; Zhang X; Chen K
    Nat Commun; 2016 May; 7():11406. PubMed ID: 27147225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment.
    Omar HA; El-Serafi AT; Hersi F; Arafa EA; Zaher DM; Madkour M; Arab HH; Tolba MF
    FEBS J; 2019 Sep; 286(18):3540-3557. PubMed ID: 31306553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
    Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
    Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
    Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
    J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA
    Zhao L; Hu K; Cao J; Wang P; Li J; Zeng K; He X; Tu PF; Tong T; Han L
    Aging (Albany NY); 2019 Sep; 11(17):7098-7122. PubMed ID: 31503007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
    Luan T; Zhang X; Wang S; Song Y; Zhou S; Lin J; An W; Yuan W; Yang Y; Cai H; Zhang Q; Wang L
    Oncotarget; 2017 Sep; 8(44):76153-76164. PubMed ID: 29100300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
    Jia L; Xi Q; Wang H; Zhang Z; Liu H; Cheng Y; Guo X; Zhang J; Zhang Q; Zhang L; Xue Z; Li Y; Da Y; Zhao P; Zhang R
    Biochem Biophys Res Commun; 2017 Jun; 488(2):425-431. PubMed ID: 28511795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long non-coding RNA MIAT regulates zinc finger E-box binding homeobox 1 expression by sponging miR-150 and promoteing cell invasion in non-small-cell lung cancer.
    Zhang HY; Zheng FS; Yang W; Lu JB
    Gene; 2017 Oct; 633():61-65. PubMed ID: 28843520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA MIAT/miR-148b/PAPPA axis modifies cell proliferation and migration in ox-LDL-induced human aorta vascular smooth muscle cells.
    Zhou Y; Ma W; Bian H; Chen Y; Li T; Shang D; Sun H
    Life Sci; 2020 Sep; 256():117852. PubMed ID: 32470448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
    Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
    Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.